Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Postoperative cognitive dysfunction is a well-recognized complication of surgery. The aim of the study is to investigate whether cognitive dysfunction is reduced by the use of modafinil as shown by neurocognitive testing.The treatment effects will be evaluated compared to placebo as well as a non-surgical group.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Preoperative modafinil + postoperative placebo | Active Comparator |
| |
| Preoperative modafinil + postoperative modafinil | Active Comparator |
| |
| Preoperative placebo + postoperative placebo | Placebo Comparator |
| |
| Control group | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Preoperative modafinil + postoperative placebo | Drug | 200 mg modafinil pre-operatively and placebo immediately post-operatively. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rey Auditory Verbal Learning Test (RAVLT) scores | Rey Auditory Verbal Learning Test (RAVLT) scores will be used to assess memory and learning ability in the auditory-verbal domain. The RAVLT begins with a list of 15 words, which an examiner reads aloud at the rate of one per second. The patient's task is to repeat all the words he or she can remember, in any order. This procedure is carried out a total of five times. Then, the examiner presents a second list of 15 words, allowing the patient only one attempt at recall. Immediately following this, the patient is asked to remember as many words as possible from the first list. For each trial a maximum score of 15 can be obtained, which would reflect excellent memory. The obtained scores per individual trial will be compared between the 4 different arms. The RAVLT will be administered preoperatively, immediately postoperatively in the PACU (except the non-surgical control group), at 1 week and at 3 months postoperatively. | 3 months |
Not provided
Not provided
Inclusion Criteria:
American Society of Anesthesiologists class I or II
Elective surgery
Surgery requiring general anesthesia
4.) Control Group will be-females & males 65 and older not scheduled for any surgical procedures for at least a 3 month period.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000079690 | Postoperative Cognitive Complications |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D060825 | Cognitive Dysfunction |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Preoperative modafinil + postoperative modafinil | Drug | 200 mg modafinil pre-operatively and 200 mg modafinil immediately post-operatively. |
|
| Preoperative placebo + postoperative placebo | Drug | Placebo pre-operatively and placebo immediately post-operatively. |
|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |